Author Question: A single-payer system is different from a public option in that under a single-payer system, ... (Read 59 times)

mckennatimberlake

  • Hero Member
  • *****
  • Posts: 559
A single-payer system is different from a public option in that under a single-payer system, __________, while under a public option, __________.
 
  A)government is the sole provider of health insurance;government replaces private insurers in the marketplace
  B)individuals provide for their own health insurance; government provides health insurance for all citizens
  C)government is the sole provider of health insurance; government competes with private insurers in the open market
  D)government provides substantial subsidies for individuals to purchase private health insurance; government is the sole health insurance provider

Question 2

How did the New Deal exacerbate the institutional problems of presidential power?
 
  A)It contributed to diminished expectations on the part of the public, which increased opportunities for presidents to increase their power.
  B)It diminished the importance of domestic issues, which was the main issue area in which the president had influence.
  C)It increased the issues that presidents must deal with but did not expand their formal powers.
  D)It unbalanced executive-legislative relations by increasing the powers of Congress while eliminating many formal presidential powers.



coyin

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

C

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The calories found in one piece of cherry cheesecake could light a 60-watt light bulb for 1.5 hours.

Did you know?

People with alcoholism are at a much greater risk of malnutrition than are other people and usually exhibit low levels of most vitamins (especially folic acid). This is because alcohol often takes the place of 50% of their daily intake of calories, with little nutritional value contained in it.

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Inotropic therapy does not have a role in the treatment of most heart failure patients. These drugs can make patients feel and function better but usually do not lengthen the predicted length of their lives.

For a complete list of videos, visit our video library